Toshima Z Parris
10PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Apr 16, 2025
Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western Sweden.Anna-Karin Tzikas, Erik Holmberg, Toshima Z Parris
|Aug 13, 2024
Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties.Peter Larsson, Maria Cristina De Rosa, Benedetta Righino
|Aug 10, 2024
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers.Peter Larsson, Maxim Olsson, Sithumini Sarathchandra
|Jul 13, 2024
Effects of Recombinant α<sub>1</sub>-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to <sup>177</sup>Lu-Octreotate.Charlotte Ytterbrink, Emman Shubbar, Toshima Z Parris
|Jan 29, 2024
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer.Peter Larsson, Daniella Pettersson, Maxim Olsson
|Jun 02, 2021
Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts.Nina Oparina, Malin C Erlandsson, Anna Fäldt Beding
Pageof 2
Frequent Collaborators
3 joint publications
Per Karlsson
2 joint publications
Eva Forssell-Aronsson
1 joint publications
Nina Oparina
1 joint publications
Malin C Erlandsson
1 joint publications
Anna Fäldt Beding
1 joint publications
Maria I Bokarewa
1 joint publications
Jana Biermann
1 joint publications
Katarina Truvé
1 joint publications
Dzeneta Vizlin-Hodzic
1 joint publications
Hans Ågren
